| Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model RM Granich, CF Gilks, C Dye, KM De Cock, BG Williams The Lancet 373 (9657), 48-57, 2009 | 2494 | 2009 |
| The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings CF Gilks, S Crowley, R Ekpini, S Gove, J Perriens, Y Souteyrand, ... The lancet 368 (9534), 505-510, 2006 | 934 | 2006 |
| Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings G Meintjes, SD Lawn, F Scano, G Maartens, MA French, W Worodria, ... The Lancet infectious diseases 8 (8), 516-523, 2008 | 903 | 2008 |
| 23–valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial N French, J Nakiyingi, LM Carpenter, E Lugada, C Watera, K Moi, ... The Lancet 355 (9221), 2106-2111, 2000 | 574 | 2000 |
| Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults N French, K Gray, C Watera, J Nakiyingi, E Lugada, M Moore, D Lalloo, ... Aids 16 (7), 1031-1038, 2002 | 520 | 2002 |
| A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults N French, S Gordon S, T Mwalukomo, S White, E Zijlstra ... C Gilks New England Journal of Medicine 362 (9), 812-822, 2010 | 472* | 2010 |
| TB/HIV: a clinical manual AD Harries, D Maher, S Graham, CF Gilks World Health Organization, 2004 | 451 | 2004 |
| Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach: executive summary WH Organization World Health Organization, 2002 | 390 | 2002 |
| Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment DE Bennett, M Myatt, S Bertagnolio, D Sutherland, CF Gilks Antiviral therapy 13 (2_suppl), 25-36, 2008 | 383 | 2008 |
| The World Health Organization's global strategy for prevention and assessment of HIV drug resistance DE Bennett, S Bertagnolio, D Sutherland, CF Gilks Antiviral therapy 13 (2_suppl), 1-13, 2008 | 382 | 2008 |
| Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial DART, Trial, team The Lancet 375 (9709), 123-131, 2010 | 367 | 2010 |
| Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya CF Gilks, RJ Brindle, RS Newnham, WM Watkins, PG Waiyaki, JBO Were, ... The Lancet 336 (8714), 545-549, 1990 | 360 | 1990 |
| Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1—positive persons in Uganda P Kaleebu, N French, C Mahe, D Yirrell, C Watera, F Lyagoba, J Nakiyingi, ... The Journal of infectious diseases 185 (9), 1244-1250, 2002 | 347 | 2002 |
| Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence MA Gordon, HT Banda, M Gondwe, SB Gordon, MJ Boeree, AL Walsh, ... Aids 16 (12), 1633-1641, 2002 | 340 | 2002 |
| Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and … RK Gupta, A Hill, AW Sawyer, A Cozzi-Lepri, V von Wyl, S Yerly, VD Lima, ... The Lancet infectious diseases 9 (7), 409-417, 2009 | 322 | 2009 |
| The global fight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectives M Vitoria, R Granich, CF Gilks, C Gunneberg, M Hosseini, W Were, ... American journal of clinical pathology 131 (6), 844-848, 2009 | 310 | 2009 |
| Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach EJ Schouten, A Jahn, D Midiani, SD Makombe, A Mnthambala, Z Chirwa, ... The Lancet 378 (9787), 282-284, 2011 | 307 | 2011 |
| Isolation of Mycobacterium avium complex from water in the United States, Finland, Zaire, and Kenya CF Von Reyn, RD Waddell, T Eaton, RD Arbeit, JN Maslow, TW Barber, ... Journal of clinical microbiology 31 (12), 3227-3230, 1993 | 304 | 1993 |
| Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults N French, J Nakiyingi, E Lugada, C Watera, JAG Whitworth, CF Gilks Aids 15 (7), 899-906, 2001 | 297 | 2001 |
| Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis P Nunn, R Brindle, K Wasunna, C Gilks, M Omwega, J Were, D Kibuga, ... The Lancet 337 (8742), 627-630, 1991 | 273 | 1991 |